Innovative Statistics in Regulatory Science

Innovative Statistics in Regulatory Science
Author :
Publisher : CRC Press
Total Pages : 553
Release :
ISBN-10 : 9781000710038
ISBN-13 : 1000710033
Rating : 4/5 (033 Downloads)

Book Synopsis Innovative Statistics in Regulatory Science by : Shein-Chung Chow

Download or read book Innovative Statistics in Regulatory Science written by Shein-Chung Chow and published by CRC Press. This book was released on 2019-11-18 with total page 553 pages. Available in PDF, EPUB and Kindle. Book excerpt: Statistical methods that are commonly used in the review and approval process of regulatory submissions are usually referred to as statistics in regulatory science or regulatory statistics. In a broader sense, statistics in regulatory science can be defined as valid statistics that are employed in the review and approval process of regulatory submissions of pharmaceutical products. In addition, statistics in regulatory science are involved with the development of regulatory policy, guidance, and regulatory critical clinical initiatives related research. This book is devoted to the discussion of statistics in regulatory science for pharmaceutical development. It covers practical issues that are commonly encountered in regulatory science of pharmaceutical research and development including topics related to research activities, review of regulatory submissions, recent critical clinical initiatives, and policy/guidance development in regulatory science. Devoted entirely to discussing statistics in regulatory science for pharmaceutical development. Reviews critical issues (e.g., endpoint/margin selection and complex innovative design such as adaptive trial design) in the pharmaceutical development and regulatory approval process. Clarifies controversial statistical issues (e.g., hypothesis testing versus confidence interval approach, missing data/estimands, multiplicity, and Bayesian design and approach) in review/approval of regulatory submissions. Proposes innovative thinking regarding study designs and statistical methods (e.g., n-of-1 trial design, adaptive trial design, and probability monitoring procedure for sample size) for rare disease drug development. Provides insight regarding current regulatory clinical initiatives (e.g., precision/personalized medicine, biomarker-driven target clinical trials, model informed drug development, big data analytics, and real world data/evidence). This book provides key statistical concepts, innovative designs, and analysis methods that are useful in regulatory science. Also included are some practical, challenging, and controversial issues that are commonly seen in the review and approval process of regulatory submissions. About the author Shein-Chung Chow, Ph.D. is currently a Professor at Duke University School of Medicine, Durham, NC. He was previously the Associate Director at the Office of Biostatistics, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA). Dr. Chow has also held various positions in the pharmaceutical industry such as Vice President at Millennium, Cambridge, MA, Executive Director at Covance, Princeton, NJ, and Director and Department Head at Bristol-Myers Squibb, Plainsboro, NJ. He was elected Fellow of the American Statistical Association and an elected member of the ISI (International Statistical Institute). Dr. Chow is Editor-in-Chief of the Journal of Biopharmaceutical Statistics and Biostatistics Book Series, Chapman and Hall/CRC Press, Taylor & Francis, New York. Dr. Chow is the author or co-author of over 300 methodology papers and 30 books.


Innovative Statistics in Regulatory Science Related Books

Innovative Statistics in Regulatory Science
Language: en
Pages: 553
Authors: Shein-Chung Chow
Categories: Mathematics
Type: BOOK - Published: 2019-11-18 - Publisher: CRC Press

GET EBOOK

Statistical methods that are commonly used in the review and approval process of regulatory submissions are usually referred to as statistics in regulatory scie
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
Language: en
Pages: 118
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2012-04-04 - Publisher: National Academies Press

GET EBOOK

The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the sa
Innovative Methods for Rare Disease Drug Development
Language: en
Pages: 321
Authors: Shein-Chung Chow
Categories: Mathematics
Type: BOOK - Published: 2020-11-11 - Publisher: CRC Press

GET EBOOK

In the United States, a rare disease is defined by the Orphan Drug Act as a disorder or condition that affects fewer than 200,000 persons. For the approval of "
Pharmaceutical Regulatory Science (English Edition)
Language: en
Pages: 144
Authors:
Categories: Education
Type: BOOK - Published: 2021-03-09 - Publisher: Thakur Publication Private Limited

GET EBOOK

Buy E-Book of Pharmaceutical Regulatory Science (English Edition) Book For B.Pharm 8th Semester of U.P. State Universities
Statistical Methods in Healthcare
Language: en
Pages: 533
Authors: Frederick W. Faltin
Categories: Medical
Type: BOOK - Published: 2012-07-24 - Publisher: John Wiley & Sons

GET EBOOK

Statistical Methods in Healthcare In recent years the number of innovative medicinal products and devices submitted and approved by regulatory bodies has declin